Document is current
Any future updates will be listed below
-
Authors
Shan, Divya M. https://orcid.org/0009-0000-1957-6622
Chandy, Rithi J.
Fultz, Andrew
Sanders, John W.
Feldman, Steven R.
- License Information
-
More Information
Article History
Received: 6 September 2023
Revised: 6 September 2023
Accepted: 25 January 2024
First Online: 2 March 2024
Declarations
:
: Feldman has received research, speaking, and/or consulting support from AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Eurofins, Forte, Galderma, Helsinn, Janssen, Leo Pharma, Micreos, Mylan, Novartis, Ono, Ortho Dermatology, Pfizer, Regeneron, Samsung, Sanofi, Sun Pharma, UCB, Verrica, Voluntis, and vTv Therapeutics. He is founder and part owner of Causa Research and holds stock in Sensal Health. Shan, Chandy, Fultz, and Sanders have no relevant financial or non-financial conflicts to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
